Muscle Pharm Co.. CEO Acquires $169,050 in Stock (MSLP)
Muscle Pharm Co.. (NASDAQ:MSLP) CEO Brad J. Pyatt acquired 15,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were purchased at an average cost of $11.27 per share, with a total value of $169,050.00. Following the completion of the acquisition, the chief executive officer now directly owns 555,722 shares in the company, valued at approximately $6,262,987. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Shares of Muscle Pharm Co.. (NASDAQ:MSLP) traded up 0.46% during mid-day trading on Friday, hitting $11.00. The stock had a trading volume of 40,765 shares. Muscle Pharm Co.. has a 52 week low of $6.16 and a 52 week high of $12.60. The stock has a 50-day moving average of $11.62 and a 200-day moving average of $8.9. The company’s market cap is $112.3 million.
Muscle Pharm Co.. (NASDAQ:MSLP) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.08) by $0.11. On average, analysts predict that Muscle Pharm Co.. will post $0.15 earnings per share for the current fiscal year.
MusclePharm Corporation (NASDAQ:MSLP) is engaged in the business of providing personal fitness training using isometric techniques (Tone in Twenty).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.